Related Experiment Video
Updated: Aug 15, 2026

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
Published on: February 24, 2014
Development and qualification of an automated capillary Western method for the identification of polysaccharide
Alyssa Deiss1, John W Loughney1, Richard R Rustandi1
1Analytical Research Development, Merck & Co., Inc., Rahway, NJ, USA.
Insights
A new assay accurately identifies individual polysaccharides in Pneumococcal conjugate vaccines (PCVs). This quality control method ensures vaccine efficacy and safety for adults and infants against Streptococcus pneumoniae infections.
Area of Science:
- Vaccinology
- Analytical Chemistry
- Microbiology
Background:
- Streptococcus pneumoniae infections pose significant mortality risks in adults and infants.
- Pneumococcal conjugate vaccines (PCVs) are crucial for disease prevention.
- Accurate identification of polysaccharide serotypes in multi-valent PCVs is essential for quality control.
Purpose of the Study:
- To develop and qualify an analytical assay for identifying individual polysaccharide components in multi-valent PCVs.
- To ensure the quality and consistency of PCV products, including Vaxneuvance™.
Main Methods:
- Development of an identity assay utilizing an automated capillary western system (Simple Western).
- Implementation of a multi-valent system suitability sample (SSS) for determining individual polysaccharide components.
- Rigorous analytical development and optimization of the assay.
Main Results:
- The developed Simple Western assay successfully identified individual polysaccharide components within a multi-valent PCV.
- The assay was qualified for use in the clinical release of PCVs.
- Demonstrated high efficacy of PCVs for adult and pediatric doses.
Conclusions:
- The automated capillary western system provides a robust method for PCV identity testing.
- This assay is critical for ensuring the quality attribute of specific polysaccharide identification in complex vaccine formulations.
- The qualified assay supports the clinical release of PCVs, contributing to public health efforts against pneumococcal disease.
Abstract:
Streptococcus pneumoniae bacterial infection causes mortality in both adults and infants. To mitigate the impact of the disease, several Pneumococcal conjugate vaccines (PCVs) have been manufactured for the U.S. market, including the recent approval of the 15-valent PCV Vaxneuvance™ from MSD. These vaccines demonstrate high efficacy for both the adult and pediatric dose. These PCVs contain multiple unique serotypes in the final, formulated vaccine product, and identifying a specific polysaccharide, in the presence of other serotypes, is a critical quality attribute that must be demonstrated through analytical testing. Here we describe the development and qualification of an identity assay using an automated capillary western system, called Simple Western, implementing a multi-valent system suitability sample (SSS) to determine individual polysaccharide components. The assay was optimized through rigorous analytical development and was successfully qualified for use in the clinical release of the PCV.
More Related Videos
Related Concept Videos
Rapid Identification of Pathogens
Automated Microbial Diagnostics

